Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Althea Group.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Althea to start selling medicinal cannabis in Ireland
Health & Biotech
ASX Health Stocks: Here’s a highlight from today’s half-year result announcements
Health & Biotech
ASX Health Stocks: Resonance gets green light in US
News
Market Highlights and 5 ASX Small Caps to watch on Tuesday
News
Weed Week: California legalises hemp and Aussie medicinal cannabis use hits all-time high
Health & Biotech
In Canada, cannabis is as big as autos… and these ASX stocks are in for the ride
Explainers
CBD Oil: The ultimate investor’s guide to a potential $64 billion global market
News
Weed Week: Cannabis-infused drinks market could reach US$2.8 billion by 2025
News
Closing Bell: ASX drifts sideways, hot lithium stock Pan Asia keeps on booming
Health & Biotech
ASX Health Stocks: Dimerix commences Phase 3 trial, while IDT scoots 10pc after restoring profit
Mining
ASX Pot Stocks: BOD Australia jumps 12% on record $7.52 million revenue for FY21
Health & Biotech
Weed Week: Connecticut and Mexico on board cannabis bandwagon, as Rinehart enters the industry
News
Last Orders: ASX back in the red today copping an 0.6 per cent hit
News
Market highlights and 5 ASX small caps to watch on Wednesday
News
Last Orders: Despite losing week, best month in six for small caps
Health & Biotech
Cann Group, Emyria team up in bid to gain TGA approval for low-dose CBD gelcap
News